Skip to content
Screener

NeoGenomics NEO Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$51M-4.5%
Quest Diagnostics logo
Quest DiagnosticsDGX
$678M+3.5%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$3.54M+68.2%
Personalis, Inc. logo
Personalis, Inc.PSNL
$14.96M-6.8%
Guardant Health logo
Guardant HealthGH
4.5%+0.7pp
Natera, Inc. logo
Natera, Inc.NTRA
6.6%-9,512,800,258pp

Other financials

Income statement

See full
Revenue$201.7M+11.2%
Gross profit$91.9M+18.9%
Operating income-$9.8M+79.5%
Net income$2.2M+105%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$145.5M-5.9%
Total debt$448.4M+534%
Total equity$785.7M-8.0%
Total assets$1.4B-3.0%

Cash flow

See full
Operating cash flow$20.0M-1.8%
CapEx$8.2M+30.0%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$2.14B+184%
Enterprise value$2.44B+265%
P/S2.8×+1.7×

Profitability

See full
Gross margin43.9%0.0pp
Operating margin-8.9%-2.8pp
Net margin-6.8%-2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-6.3%-2.0pp
Debt / equity0.6×+0.5×
Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001077183-26-000059
Line item(unaudited)June 30, 2026December 31, 2025
Other current assets9,8077,417
Total current assets381,478376,286
Property and equipment (net of accumulated depreciation of $223,479 and $209,057, respectively)80,93884,834
Operating lease right-of-use assets78,60678,444
Financing lease right-of-use assets6,65354
Intangible assets, net271,262286,528
Goodwill523,995524,344
Other assets9,3119,340

Item 1. Financial Statements (unaudited)

FAQ

What is NeoGenomics's operating lease ROU assets?
NeoGenomics (NEO) reported operating lease ROU assets of $78.61M in Q2 2026.
How has NeoGenomics's operating lease ROU assets changed year-over-year?
NeoGenomics's operating lease ROU assets decreased by 5.1% year-over-year, from $82.87M to $78.61M.
What is the long-term trend for NeoGenomics's operating lease ROU assets?
Over 5 years (2020 to 2025), NeoGenomics's operating lease ROU assets has grown at a 11.4% compound annual growth rate (CAGR), from $45.79M to $78.44M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about NeoGenomics's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude